Fujian Aonong Biological Technology Group Incorporation Ltd Total Assets
Fujian Aonong Biological Technology Group Incorporation Ltd total assets. Based on the latest financial reports, Fujian Aonong Biological Technology Group Incorporation Ltd (603363) holds total assets worth CN¥8.81 Billion CNY (≈ $1.29 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see 603363 market cap for the company's overall valuation and market capitalisation.
Total Assets of Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
Total assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025. This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's total assets have evolved over time, based on quarterly financial data. See Fujian Aonong Biological Technology Grou stock price for real-time trading data and today's change.
Fujian Aonong Biological Technology Group Incorporation Ltd - Asset Composition Analysis
Fujian Aonong Biological Technology Group Incorporation Ltd Total Assets Breakdown (December 2025)
Fujian Aonong Biological Technology Group Incorporation Ltd total assets breakdown as of December 2025. Fujian Aonong Biological Technology Group Incorporation Ltd's total assets of CN¥8.81 Billion consist of 38.1% current assets and 61.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 8.0% |
| Accounts Receivable | CN¥509.86 Million | 5.8% |
| Inventory | CN¥955.40 Million | 10.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥315.96 Million | 3.6% |
| Goodwill | CN¥337.74 Million | 3.9% |
Asset Composition Trend (2013–2025)
This chart illustrates how Fujian Aonong Biological Technology Group Incorporation Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Fujian Aonong Biological Technology Grou to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Fujian Aonong Biological Technology Group Incorporation Ltd's current assets represent 38.1% of total assets in 2025, a decrease from 70.7% in 2013.
- Cash Position: Cash and equivalents constituted 8.0% of total assets in 2025, down from 18.3% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 2.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 10.9% of total assets.
Fujian Aonong Biological Technology Group Incorporation Ltd Competitors by Total Assets
Key competitors of Fujian Aonong Biological Technology Group Incorporation Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
New Hope Liuhe Co Ltd
SHE:000876
|
China | CN¥116.39 Billion |
|
Heilongjiang Agriculture Co Ltd
SHG:600598
|
China | CN¥15.35 Billion |
|
Yunnan Shennong Agricultural Industry Group Co Ltd
SHG:605296
|
China | CN¥7.16 Billion |
|
Austevoll Seafood ASA
OL:AUSS
|
Norway | Nkr50.27 Billion |
|
SLC Agrícola S.A
SA:SLCE3
|
Brazil | R$19.99 Billion |
|
Astra Agro Lestari Tbk
JK:AALI
|
Indonesia | Rp30.51 Trillion |
|
Shandong Xiantan Co Ltd
SHE:002746
|
China | CN¥8.44 Billion |
|
Shandong Teamgene Technology Co. Ltd. A
SHG:603151
|
China | CN¥3.88 Billion |
Fujian Aonong Biological Technology Group Incorporation Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.89 | 0.95 | 0.54 |
| Quick Ratio | 0.62 | 0.70 | 0.23 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥-430.85 Million | CN¥-163.67 Million | CN¥-4.23 Billion |
Fujian Aonong Biological Technology Group Incorporation Ltd - Advanced Valuation Insights
This section examines the relationship between Fujian Aonong Biological Technology Group Incorporation Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.85 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -8.0% |
| Total Assets | CN¥8.74 Billion |
| Market Capitalization | $1.08 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Fujian Aonong Biological Technology Group Incorporation Ltd's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Fujian Aonong Biological Technology Group Incorporation Ltd's assets decreased by 8.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Fujian Aonong Biological Technology Group Incorporation Ltd (2013–2025)
The table below shows the annual total assets of Fujian Aonong Biological Technology Group Incorporation Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥8.74 Billion ≈ $1.28 Billion |
-8.04% |
| 2024-12-31 | CN¥9.51 Billion ≈ $1.39 Billion |
-30.23% |
| 2023-12-31 | CN¥13.63 Billion ≈ $1.99 Billion |
-26.98% |
| 2022-12-31 | CN¥18.66 Billion ≈ $2.73 Billion |
+9.12% |
| 2021-12-31 | CN¥17.10 Billion ≈ $2.50 Billion |
+42.28% |
| 2020-12-31 | CN¥12.02 Billion ≈ $1.76 Billion |
+144.20% |
| 2019-12-31 | CN¥4.92 Billion ≈ $720.19 Million |
+48.91% |
| 2018-12-31 | CN¥3.31 Billion ≈ $483.63 Million |
+30.22% |
| 2017-12-31 | CN¥2.54 Billion ≈ $371.40 Million |
+48.28% |
| 2016-12-31 | CN¥1.71 Billion ≈ $250.48 Million |
+26.96% |
| 2015-12-31 | CN¥1.35 Billion ≈ $197.29 Million |
+45.46% |
| 2014-12-31 | CN¥926.86 Million ≈ $135.63 Million |
+30.46% |
| 2013-12-31 | CN¥710.45 Million ≈ $103.96 Million |
-- |
About Fujian Aonong Biological Technology Group Incorporation Ltd
Fujian Aonong Biological Technology Group Incorporation Limited engages in the feed, pig farming, food, supply chain services, and other businesses in China and internationally. It researches and develops, produces, and sells feed products, such as pig feed, poultry feed, aquatic feed, ruminant, and other products; and operates pig breeding farms. The company also engages in the pig slaughtering … Read more